Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced that the US Food and Drug Administration (FDA) has cleared the company's ...

Medistep Healthcare's IPO to open on August 8; Issue price fixed at Rs. 43 per share: Our Bureau, Mumbai Wednesday, August 6, 2025, 14:15 Hrs [IST] Medistep Healthcare Limited, a ...

Lupin reports 51.5 per cent growth in net profit during Q1FY26: Our Bureau, New Delhi Wednesday, August 6, 2025, 14:30 Hrs [IST] Lupin Ltd has posted a growth of 51.5 per cent in ...

Innovent Biologics receives US FDA clearance to initiate phase 1 clinical trial of novel oral GLP-1R agonist, IBI3032: San Francisco Wednesday, August 6, 2025, 14:00 Hrs [IST] Inn ...